Guru Ownership Trend
Guru Analysis for Rapport Therapeutics, Inc. (RAPP)
Rapport Therapeutics, Inc. (RAPP), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $1.48 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.27 M net outflow during the quarter.
Recent activity highlights Cliff Asness who increased their stake by 22.2%. Conversely, Renaissance Technologies (RenTech) reduced exposure by 91.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for Rapport Therapeutics, Inc. (RAPP)
Major holders include Cliff Asness ($798,208), Renaissance Technologies (RenTech) ($303,513). According to the latest reported data, 2 tracked investment managers collectively hold approximately 35,210 shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.27 M, with 1 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited RAPP. The total reported sell value was $3.41 M.
Yes, 0 managers opened new positions in RAPP, and 1 increased their existing holdings. The total reported buy value was $144,935.3.